These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8302177)
41. Accessing the medical devices market in Egypt and Saudi Arabia: a systematic review of policies and regulations. Gad M; Kriza C; Fidler A; Kolominsky-Rabas P Expert Rev Med Devices; 2016 Jul; 13(7):683-96. PubMed ID: 27268662 [TBL] [Abstract][Full Text] [Related]
42. Developing innovative implantable medical devices. Hodgins D Med Device Technol; 2004 May; 15(4):22-4. PubMed ID: 15303559 [TBL] [Abstract][Full Text] [Related]
43. How to cope in today's health care market. Feldstein PJ Physicians Manage; 1984 Oct; 24(10):165, 168-9, 173-4 passim. PubMed ID: 10268440 [No Abstract] [Full Text] [Related]
44. Industry economics in the United States. Med Device Technol; 2004 Apr; 15(3):34-6. PubMed ID: 15255538 [TBL] [Abstract][Full Text] [Related]
45. Medical marketing mixture--update. DeSalvo RJ Med Mark Media; 1978 Sep; 13(9):21-2, 24, 26 passim. PubMed ID: 10238520 [No Abstract] [Full Text] [Related]
46. When names make claims: ethical issues in medical device marketing. Bramstedt KA Ethics Med; 2004; 20(2):47-57. PubMed ID: 15468483 [No Abstract] [Full Text] [Related]
47. Lowest charge level for medical services, supplies, and equipment: final regulations. Fed Regist; 1978 Jul; 43(144):32294-301. PubMed ID: 10297137 [No Abstract] [Full Text] [Related]
48. Developing winning products, Part I. Williams S Med Device Technol; 1998 Nov; 9(9):26-30, 32. PubMed ID: 10344881 [TBL] [Abstract][Full Text] [Related]
49. A pseudo market. Holter EA Minn Med; 2005 Sep; 88(9):76. PubMed ID: 16475417 [No Abstract] [Full Text] [Related]
50. Using decision support systems to market prepaid medical plans. Forgionne GA J Health Care Mark; 1991 Dec; 11(4):22-38. PubMed ID: 10115899 [TBL] [Abstract][Full Text] [Related]
51. Managed care--evolution or revolution? Lewis TS Med Device Technol; 1996 Dec; 7(10):24-6. PubMed ID: 10164054 [TBL] [Abstract][Full Text] [Related]
52. Belgium: sophisticated market with an eye on imports. McKnight WM MPS; 1980 Jan; 11(1):16, 21. PubMed ID: 10245022 [No Abstract] [Full Text] [Related]
53. Cell therapy industry: billion dollar global business with unlimited potential. Mason C; Brindley DA; Culme-Seymour EJ; Davie NL Regen Med; 2011 May; 6(3):265-72. PubMed ID: 21548728 [No Abstract] [Full Text] [Related]
54. [Marketing study of the Russian market of anthelmintics. Assortment analysis]. Kral'ko TB; Lopatina NB; Lebedeva MN Med Parazitol (Mosk); 2001; (2):48-51. PubMed ID: 11702462 [TBL] [Abstract][Full Text] [Related]
55. [International specialization in the production of medical instruments in the member countries of COMECON]. Izmailov AKh; Larionova LA; Pavelkin VA Med Tekh; 1987; (6):29-34. PubMed ID: 3441192 [No Abstract] [Full Text] [Related]
56. Winds of change in the marketing of medical devices. Spyrison DE Med Mark Media; 1983 Feb; 18(2):32-4. PubMed ID: 10260278 [No Abstract] [Full Text] [Related]
58. The acquisition and maintenance of medical equipment. Barger M; Bandy C Clin Eng News; 1977; 5(3):4-9. PubMed ID: 10304715 [No Abstract] [Full Text] [Related]
59. [The characteristics of medical supplies under current conditions]. Umarov SZ; Mazur PIu Voen Med Zh; 1993 Oct; (10):8-9, 80. PubMed ID: 8303860 [TBL] [Abstract][Full Text] [Related]
60. [Basic trends in the design of medical instruments]. Zelenov ES Med Tekh; 1993; (5):4-5. PubMed ID: 8302181 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]